Primary Record
Lestaurtinib
- In stock
- 3,283 g
- Purity
- 99.6 %
- CAS
- 111358-88-4
Compound Identifiers & Properties
- CAS
- 111358-88-4
- PubChem CID
- 126565
- SMILES
- C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O
- Canonical SMILES
- C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
Names & Synonyms
- Lestaurtinib
- CEP-701
- 111358-88-4
- apalutamide
- lestaurtinibum
- Lestaurtinib?
- 4otg
- CEP-701 hydrate
- CEP 701
- KT-5555
- SPM-924
- Lestaurtinib [USAN]
- SP924
- KT5555
- CEP701
- Lestaurtinib (USAN/INN)
- Lestaurtinib [USAN:INN]
- Lestaurtinib; CEP701
- SP 924
- SP-924
- RefChem:798967
- DO989GC5D1
- GlyTouCan:G20293PV
- UNII-DO989GC5D1
- DTXSID5046778
- KT-555
- LESTAURTINIB [INN]
- D0V9WF
- CHEMBL603469
- C26H21N3O4
- KT 5555
- DTXCID3026778
- LESTAURTINIB [MART.]
- cc-713
- LESTAURTINIB [WHO-DD]
- UIARLYUEJFELEN-LROUJFHJSA-N
- GTPL5672
- orb1707082
- SCHEMBL12963759
- CHEBI:91471
- CTK8F0849
- GLXC-07175
- BCP06977
- G20293PV
- ZINC3781738
- Tox21_112633
- BBF-03786
- BDBM50308060
- CID126565
- EX-A15190
- HB1429
- MFCD12828858
- NCGC00168772-01
- NSC772196
- NSC800782
- AKOS024457603
- C26-H21-N3-O4
- AC-5243
- AM81228
- CID:126565
- DB06469
- EBC-383043
- FL24870
- NSC-772196
- NSC-800782
- NCGC00168772-02
- NCGC00168772-03
- NCGC00168772-04
- A-154475.0
- AN-11201
- DA-64923
- HY-50867
- MS-27884
- A-154475
- SID:249815159
- A 1544750
- PA-126565
- RT-013568
- A 154475.0
- A4513
- CAS-111358-88-4
- CS-0004336
- FT-0670762
- NS00069188
- V0246
- D04696
- G13628
- A857483
- C119379
- (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
- Q6531771
- BRD-K23192422-001-01-1
- (5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one
- Z2037281011
- (15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one
- (5S,6S,8R)-6-Hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13-one
- 9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-
- (15S,16S)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo(12.11.2.115,18.02,6.07,27.08,13.019,26.020,25)octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one
- (15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo(12.11.2.1^(15,18).0^(2,6).0^(7,27).0^(8,13).0^(19,26).0^(20,25))octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one
- (15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one
- (15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaen-3-one
- (4bR,5S,6S,8R,8aS)-6-hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacen-13-one
- (5R,7S,8S)-7-hydroxy-7-(hydroxymethyl)-8-methyl-5,6,7,8,13,14-hexahydro-15H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-15-one
- (5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacen-13-one
- (9S,10S,12R)-10-Hydroxy-10-(hydroxymethyl)-9-methyl-2,3,9,10,11,12-hexahydro-9,12-epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one
- (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3 inverted exclamation mark ,2 inverted exclamation mark ,1 inverted exclamation mark -kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
- (9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4 -i][1,6]benzodiazocin-1-one
- 16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one
- 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoic acid
- 2V9
- 9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S-(9alpha,10beta,12alpha))-
- 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-
- CEP-701|||KT-5555|||(5S,6S,8R)-6-Hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one